KR20080078460A - Novel lactrobacillus buchneri and use thereof - Google Patents
Novel lactrobacillus buchneri and use thereof Download PDFInfo
- Publication number
- KR20080078460A KR20080078460A KR1020070018641A KR20070018641A KR20080078460A KR 20080078460 A KR20080078460 A KR 20080078460A KR 1020070018641 A KR1020070018641 A KR 1020070018641A KR 20070018641 A KR20070018641 A KR 20070018641A KR 20080078460 A KR20080078460 A KR 20080078460A
- Authority
- KR
- South Korea
- Prior art keywords
- lactobacillus
- kimchi
- culture
- gaba
- bootsneri
- Prior art date
Links
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 107
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 54
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims abstract description 53
- 235000021109 kimchi Nutrition 0.000 claims abstract description 53
- 239000000203 mixture Substances 0.000 claims abstract description 18
- 238000004519 manufacturing process Methods 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 11
- 239000007858 starting material Substances 0.000 claims abstract description 9
- 241000186679 Lactobacillus buchneri Species 0.000 claims abstract description 8
- 238000000855 fermentation Methods 0.000 claims abstract description 7
- 230000004151 fermentation Effects 0.000 claims abstract description 7
- 239000006041 probiotic Substances 0.000 claims abstract description 7
- 235000018291 probiotics Nutrition 0.000 claims abstract description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000013373 food additive Nutrition 0.000 claims abstract description 6
- 239000002778 food additive Substances 0.000 claims abstract description 6
- 238000012258 culturing Methods 0.000 claims abstract description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 3
- 239000011707 mineral Substances 0.000 claims abstract description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 3
- 229930003231 vitamin Natural products 0.000 claims abstract description 3
- 239000011782 vitamin Substances 0.000 claims abstract description 3
- 235000013343 vitamin Nutrition 0.000 claims abstract description 3
- 229940088594 vitamin Drugs 0.000 claims abstract description 3
- 241000186660 Lactobacillus Species 0.000 claims description 45
- 229940039696 lactobacillus Drugs 0.000 claims description 45
- 230000000529 probiotic effect Effects 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 abstract description 32
- 239000000463 material Substances 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000008021 deposition Effects 0.000 abstract 1
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 38
- 239000004310 lactic acid Substances 0.000 description 19
- 235000014655 lactic acid Nutrition 0.000 description 19
- 239000000047 product Substances 0.000 description 9
- 239000002609 medium Substances 0.000 description 7
- 238000004809 thin layer chromatography Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 240000007124 Brassica oleracea Species 0.000 description 6
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 6
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 6
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 239000001974 tryptic soy broth Substances 0.000 description 6
- 108010050327 trypticase-soy broth Proteins 0.000 description 6
- 108020004465 16S ribosomal RNA Proteins 0.000 description 5
- 240000001929 Lactobacillus brevis Species 0.000 description 5
- 235000013957 Lactobacillus brevis Nutrition 0.000 description 5
- 235000011194 food seasoning agent Nutrition 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 244000068988 Glycine max Species 0.000 description 4
- 235000010469 Glycine max Nutrition 0.000 description 4
- 244000199866 Lactobacillus casei Species 0.000 description 4
- 235000013958 Lactobacillus casei Nutrition 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 229940017800 lactobacillus casei Drugs 0.000 description 4
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 4
- 239000006872 mrs medium Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 description 3
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 description 3
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- QWCKQJZIFLGMSD-UHFFFAOYSA-N alpha-aminobutyric acid Chemical compound CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 235000013923 monosodium glutamate Nutrition 0.000 description 3
- 239000004223 monosodium glutamate Substances 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 235000021574 pickled cabbage Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000004007 reversed phase HPLC Methods 0.000 description 3
- 239000004460 silage Substances 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 240000002234 Allium sativum Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 240000004160 Capsicum annuum Species 0.000 description 2
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 2
- 235000007862 Capsicum baccatum Nutrition 0.000 description 2
- QWCKQJZIFLGMSD-GSVOUGTGSA-N D-alpha-aminobutyric acid Chemical compound CC[C@@H](N)C(O)=O QWCKQJZIFLGMSD-GSVOUGTGSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000003674 animal food additive Substances 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 239000001728 capsicum frutescens Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000004611 garlic Nutrition 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 235000015277 pork Nutrition 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 1
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241001454694 Clupeiformes Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000008214 Glutamate decarboxylase Human genes 0.000 description 1
- 108091022930 Glutamate decarboxylase Proteins 0.000 description 1
- 241000186612 Lactobacillus sakei Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000010716 Vigna mungo Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 235000019513 anchovy Nutrition 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000000701 neuroleptic effect Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 238000005554 pickling Methods 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
- A23B7/00—Preservation or chemical ripening of fruit or vegetables
- A23B7/10—Preserving with acids; Acid fermentation
- A23B7/105—Leaf vegetables, e.g. sauerkraut
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Abstract
Description
도 1은 김치 중에 존재하는 감마-아미노뷰티르산(GABA)의 검출곡선을 나타낸 역상 HPLC 그래프이다.1 is a reverse phase HPLC graph showing a detection curve of gamma-aminobutyric acid (GABA) present in kimchi.
도 2는 숙성기간에 따른 김치의 GABA 함량을 역상 HPLC를 이용하여 정량한 그래프이다.2 is a graph quantifying the GABA content of kimchi according to the aging period using reverse phase HPLC.
( A : 종가집 김치, B : 일미 맛김치, C : 종가집 삼겹살 묵은지)(A: Jongga House Kimchi, B: Ilmi Flavored Kimchi, C: Jongga House Pork Belly)
도 3은 본 발명에 따른 락토바실러스 부츠네리의 GABA 생성량을 정성 분석한 박층 크로마토그래피(TLC) 결과이다.Figure 3 is a thin layer chromatography (TLC) results of qualitative analysis of the GABA production amount of Lactobacillus bootsneri according to the present invention.
( 1 : J-1, 2 : E-2, 3 : E-1, 4 : O-03, 5 : O-04, 6 : H-W2, 7 : P-2, 8 : P-1, 9 : H-W1, 10 : O-05 ) (1: J-1, 2: E-2, 3: E-1, 4: O-03, 5: O-04, 6: H-W2, 7: P-2, 8: P-1, 9 : H-W1, 10: O-05)
도 4 본 발명에 따른 락토바실러스 부츠네리의 GABA 생성능과 공지의 유산균의 GABA 생성능을 비교한 그래프이다.Figure 4 is a graph comparing the GABA production capacity of Lactobacillus bootsneri according to the present invention and the GABA production capacity of known lactic acid bacteria.
( A : 락토바실러스 카제이, B : 본 발명의 락토바실러스 부츠네리 , C : 락토바실러스 브레비스)(A: Lactobacillus casei, B: Lactobacillus bootsneri of the present invention, C: Lactobacillus brevis)
본 발명은 신규한 락토바실러스 부츠네리 및 이의 용도에 관한 것으로서, 보다 상세하게는 감마-아미노뷰티르산(GABA) 고생성능을 갖는 락토바실러스 부츠네리(Lactobacillus buchneri) 및 이의 용도에 관한 것이다.The present invention relates to a novel Lactobacillus bootsneri and its use, and more particularly, to Lactobacillus buchneri and gamma-aminobutyric acid (GABA) high performance.
일반적으로 김치는 비타민 A, 비타민 B, 비타민 C 및 필수 아미노산 등을 함유하고 있고 다량의 섬유소를 가지고 있기 때문에, 변비, 동맥경화 등의 만성질환에 효과가 있으며 또한 암 예방 효과가 있다고 알려져 있다.In general, kimchi contains vitamin A, vitamin B, vitamin C and essential amino acids, and has a large amount of fiber, which is known to be effective in chronic diseases such as constipation and atherosclerosis, and also prevents cancer.
한편, 감마-아미노뷰티르산(GABA; γ-aminobutyric acid)은 포유류의 뇌속에 존재하는 아미노산으로서 글루타메이트 디카르복실라아제(Glutamate decarboxylase)에 의해 글루타메이트로부터 생성되는 신경전달물질이다. 특히, 혈관의 운동을 활성화시켜 혈압을 저하시키고(Kayahara H. and Sgiura D., Food & Development., 36(6):4-6, 2001), 뇌기능 개선작용을 하여 정신안정 및 학습능력을 증가시킨다고 알려져 있다(Ishikawa K. and Saito S., Psychopharmacology, 56:127-131, 1978; Akaga T., Food & development, 36(6):7-9, 2001). 현재, GABA 함유 차의 연구 외에도, 쌀 및 콩 발효식품, 김치 등에서 분리한 젖산균들이 GABA를 고농도로 생산한다는 연구가 다수 보고되어 있고, 분리한 젖산균을 실제 식품에 적용하여 식품 중의 GABA 함량을 높이는 기술 또한 다수 보고된 바 있다 (대한민국 특허 제10-0478491호, 제10-2006-0006342호 및 제10-2004-0096975호 참조). 김치 의 맛뿐만 아니라 기능성을 향상시키기 위한 일환으로 이러한 GABA가 다량 함유된 김치가 개발된 바 있으나(대한민국 특허출원 제 2001-14638호), 대두 단백질이나 두류 등을 첨가하여 간접적으로 GABA가 김치 내에서 생산되게 하였기 때문에, 대두나 두류 등에 의해 김치 고유의 맛이 없어질 수도 있다는 문제점이 있었다. On the other hand, gamma-aminobutyric acid (GABA; gamma-aminobutyric acid) is an amino acid present in the brain of a mammal and is a neurotransmitter produced from glutamate by glutamate decarboxylase. In particular, it activates the movement of blood vessels to lower blood pressure (Kayahara H. and Sgiura D., Food & Development ., 36 (6): 4-6, 2001), and improves brain function to improve mental stability and learning ability. It is known to increase (Ishikawa K. and Saito S., Psychopharmacology , 56: 127-131, 1978; Akaga T., Food & development , 36 (6): 7-9, 2001). Currently, in addition to the study of GABA-containing tea, many studies have reported that lactic acid bacteria isolated from fermented foods such as rice and soybeans and kimchi produce high concentrations of GABA, and technology to increase GABA content in foods by applying the isolated lactic acid bacteria to actual foods. Many have also been reported (see Korean Patent Nos. 10-0478491, 10-2006-0006342 and 10-2004-0096975). Kimchi containing a large amount of GABA has been developed as a part of improving the taste and functionality of Kimchi (Korean Patent Application No. 2001-14638), but indirectly adding soy protein or soybeans Since it was produced, there was a problem that the taste of kimchi may be lost by soybean or soybean.
본 발명자들은 김치가 숙성될수록 GABA 함량이 높아진다는 것을 발견하여 6개월 이상 숙성된 김치로부터 GABA 고생성능을 갖는 유산균을 분리하고, 이를 이용하여 김치를 제조하여 GABA 함량이 높은 기능성 김치를 제조함으로써 본 발명을 완성하였다. The present inventors found that the higher the GABA content as the kimchi is aged, isolating lactic acid bacteria having high GABA performance from kimchi aged more than 6 months, using this to produce kimchi to produce a functional kimchi with a high GABA content Was completed.
따라서, 본 발명의 목적은 GABA 고생성능을 갖는 유산균 및 이의 용도를 제공하는 것이다.Accordingly, it is an object of the present invention to provide a lactic acid bacterium having high GABA performance and its use.
상기와 같은 목적을 달성하기 위하여, 본 발명은 GABA 고생성능을 갖는 락토바실러스 부츠네리 또는 이의 배양물을 제공한다.In order to achieve the above object, the present invention provides a Lactobacillus bootsneri or culture thereof having high GABA performance.
본 발명의 다른 목적을 달성하기 위하여 본 발명은 상기 락토바실러스 부츠네리 또는 이의 배양물을 함유하는 정장용, 생균제, 사료용 및 식품첨가용 조성물을 제공한다.In order to achieve the other object of the present invention, the present invention provides a composition for formal, probiotic, feed and food additives containing the Lactobacillus bootsneri or its culture.
또한 본 발명의 또 다른 목적을 달성하기 위하여 본 발명은 상기 락토바실러 스 부츠네리 또는 이의 배양물을 함유하는 발효제품을 제공한다.In addition, the present invention provides a fermentation product containing the Lactobacillus bootsneri or its culture in order to achieve another object of the present invention.
아울러 본 발명은 상기 락토바실러스 부츠네리 또는 이의 배양물을 스타터로 이용하여 발효제품을 제조하는 방법을 제공한다.In addition, the present invention provides a method for producing a fermentation product using the Lactobacillus bootsneri or its culture as a starter.
또한 본 발명은 상기 락토바실러스 부츠네리를 김치에 스타터로 사용할 수 있도록 배양물을 제공한다. In another aspect, the present invention provides a culture so that the Lactobacillus bootsneri can be used as a starter in kimchi.
나아가 본 발명은 상기 락토바실러스 부츠네리의 배양방법을 제공한다.Furthermore, the present invention provides a method for culturing the Lactobacillus bootsneri.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명의 락토바실러스 부츠네리는 6개월 이상 숙성된 김치에서 분리된 신규한 유산균으로 GABA 고생성능이라는 점에 특징이 있다. Lactobacillus bootsneri of the present invention is characterized by the high performance of GABA as a novel lactic acid bacteria isolated from kimchi aged for 6 months or more.
본 발명에서는 숙성이 안된 김치에 비하여 6개월 이상 숙성된 묵은 김치에 GABA 함량이 더 높은 것을 확인하고(도 2 참조), 6개월 이상 묵은 김치로부터 GABA 고생성능을 갖는 신규한 유산균을 분리하였다. 상기 분리된 유산균의 동정을 수행한 결과, 락토바실러스 부츠네리에 속하는 균주임을 확인할 수 있었고, 상기 균주를 한국미생물보존센터(Korean Culture Center of Microorganisms)에 2007년 1월 10일자로 기탁하였다(기탁번호 : KCCM10835P). In the present invention, it was confirmed that the GABA content is higher in the old kimchi aged more than 6 months compared to the kimchi not aged (see FIG. 2), was isolated from the lactic acid bacteria having a high GABA high performance from kimchi 6 months or more. As a result of the identification of the isolated lactic acid bacteria, it was confirmed that the strain belonging to Lactobacillus bootsneri, the strain was deposited on January 10, 2007 to the Korea Culture Center of Microorganisms (Accession No. : KCCM10835P).
일반적인 유산균인 락토바실러스 카제이 균주는 GABA를 거의 생성하지 않고, 종래 GABA 생성능이 있는 것으로 알려져 있는 락토바실러스 브레비스는 0.17 mg/ml 정도 생성하는 것에 비하여, 본 발명에 분리 동정한 유산균인 락토바실러스 부츠네리 균주는 GABA를 13.45 mg/ml 생성하여 종래 유산균에 비하여 약 10배 이상의 GABA 생성능을 갖는다(도 4 참조). Lactobacillus casei strain, which is a common lactic acid bacterium, produces little GABA, and Lactobacillus brevis, which is known to have a conventional GABA producing ability, produces about 0.17 mg / ml. The strain produces 13.45 mg / ml of GABA has a GABA production capacity of about 10 times or more compared to conventional lactic acid bacteria (see Figure 4).
따라서 본 발명의 유산균은 GABA 고생성능을 갖는 유산균으로 인간 및 동물의 건강증진을 위한 용도, 즉 정장용, 생균제 또는 사료용 조성물로 사용될 수 있다. 상기 조성물은 본 발명의 락토바실러스 부츠네리의 파쇄된 세포벽 분획, 생균, 사균, 건조균 또는 배양물을 유효성분으로 포함할 수 있으며, 부형제 또는 담체를 추가로 포함할 수 있다. 상기 배양물은 액체배지에서 배양한 배양액 자체, 상기 배양액을 여과 또는 원심분리하여 균주를 제거한 여액(원심분리한 상등액) 등을 포함한다. 조성물 내 락토바실러스 부츠네리의 함량은 조성물의 용도 및 제형에 따라 달라질 수 있다. 본 발명에 따른 정장용 또는 생균제 조성물은 다양한 제형과 방법으로 제조 및 투여될 수 있다. 예를 들어, 락토바실러스 부츠네리 또는 이의 배양물을 약제학적 분야에서 통상적으로 사용하는 담체 및 향료와 혼합하여 정제(tablet), 트로키(troche), 캡슐(capsule), 엘릭실(elixir), 시럽(syrup), 산제(powder), 현탁제(suspension) 또는 과립제(granule) 등의 형태로 제조 및 투여될 수 있다. 상기 담체로는 결합제, 활탁제, 붕해제, 부형제, 가용화제, 분산제, 안정화제, 현탁화제 등을 사용할 수 있다. 투여방식은 경구, 비경구 또는 도포법을 사용할 수 있으나, 바람직하게는 경구투여하는 것이 바람직하다. 또한, 투여용량은 체내에서 활성성분의 흡수도, 불활성율 및 배설속도, 피투여자의 연령, 성별, 상태 등에 따라 적절히 선택할 수 있다. 또한, 본 발명에 따른 사료용 조성물은 발효사료, 배합사료, 펠렛형태 및 사일레지(silage) 등의 형태로 제조될 수 있다. 상기 발효사료는 본 발명의 락토바실러스 사케이와 여러 가지 미생물 균 또는 효소들 을 첨가함으로써 유기물을 발효시켜 제조될 수 있으며, 상기 배합사료는 여러 종류의 일반사료와 본 발명의 락토바실러스 부츠네리를 혼합하여 제조될 수 있다. 펠렛 형태의 사료는 상기 발효사료 또는 배합사료를 펠렛기로 제형화하여 제조될 수 있으며, 사일레지는 청예사료를 본 발명에 따른 락토바실러스 부츠네리로 발효시킴으로서 제조될 수 있다.Therefore, the lactic acid bacteria of the present invention can be used as a lactic acid bacteria having high GABA performance, for the purpose of improving health of humans and animals, that is, for formal use, probiotics or feed compositions. The composition may include a crushed cell wall fraction, live bacteria, dead bacteria, dry bacteria or culture of Lactobacillus bootsneri of the present invention as an active ingredient, and may further include an excipient or a carrier. The culture includes a culture solution itself cultured in a liquid medium, a filtrate (centrifuged supernatant) from which the strain is removed by filtration or centrifugation of the culture solution. The content of Lactobacillus bootsneri in the composition may vary depending on the use and formulation of the composition. Formal or probiotic compositions according to the invention may be prepared and administered in a variety of formulations and methods. For example, Lactobacillus bootsneri or its culture may be mixed with carriers and flavorings commonly used in the pharmaceutical arts for tablets, troches, capsules, elixirs, syrups. It may be prepared and administered in the form of syrup, powder, suspension or granule. As the carrier, a binder, a lubricant, a disintegrant, an excipient, a solubilizer, a dispersant, a stabilizer, a suspending agent and the like can be used. The mode of administration may be oral, parenteral or application, but preferably oral administration. In addition, the dosage may be appropriately selected depending on the absorbency, inactivation rate and excretion rate of the active ingredient in the body, age, sex, condition, etc. of the recipient. In addition, the feed composition according to the invention can be prepared in the form of fermented feed, compound feed, pellet form and silage (silage) and the like. The fermented feed may be prepared by fermenting an organic material by adding the Lactobacillus sakei and various microorganisms or enzymes of the present invention, the blended feed by mixing the various types of general feed and Lactobacillus bootsnery of the present invention Can be prepared. The feed in the form of pellets may be prepared by formulating the fermented feed or blended feed into a pellet machine, and silage may be prepared by fermenting the green feed with Lactobacillus bootsnery according to the present invention.
본 발명에 따른 락토바실러스 부츠네리 또는 이의 배양물은 김치, 음료, 이유식 등의 식품에 대한 식품첨가제로 사용될 수 있다. 아울러, 본 발명의 락토바실러스 부츠네리는 발효제품 제조를 위한 스타터(starter)로 사용될 수 있다. 상기 발효제품은 치즈, 김치, 발효생식제품 등을 포함한다. 본 발명의 락토바실러스 부츠네리를 이용한 발효제품은 당업계에 공지된 통상의 방법에 따라 제조될 수 있다. 예컨대, 현미와 율무 등의 곡류 분말에 본 발명에 따른 락토바실러스 부츠네리 또는 이를 포함하는 2-3종의 혼합 유산균을 처리하여 적정 온도에서 발효시킨 후, 백태, 찹쌀, 수수 등의 다양한 농산물을 영양적인 균형과 기호성이 우수하도록 적절히 배합하여 발효 생식제품을 제조할 수 있다. Lactobacillus bootsneri or its culture according to the present invention can be used as a food additive for food such as kimchi, beverages, baby food. In addition, the Lactobacillus bootsnery of the present invention can be used as a starter (starter) for the production of fermentation products. The fermented product includes cheese, kimchi, fermented reproductive products and the like. Fermentation products using the Lactobacillus bootsneri of the present invention can be prepared according to conventional methods known in the art. For example, after treating the grain powders such as brown rice and yulmu and the Lactobacillus bootsneri according to the present invention or 2-3 kinds of mixed lactic acid bacteria including the same, fermented at an appropriate temperature, nutrition of various agricultural products such as white rice, glutinous rice, sorghum, etc. Fermented reproductive products can be prepared by appropriate mixing to provide excellent balance and palatability.
특히, 본 발명에 따른 락토바실러스 부츠네리는 김치를 제조하는데 사용할 수 있다. 바람직하게는 소금으로 절인 배추에 고춧가루, 마늘, 생강, 대파, 무채, 설탕과 같은 일반적인 김치 양념들을 혼합한 후, 본 발명의 락토바실러스 부츠네리의 배양물을 첨가하여 김치를 제조할 수 있다. 상기 본 발명의 락토바실러스 부츠네리의 배양물은 김치 전체 중량에 대하여 0.5 ~ 5 중량% 첨가하는 것이 바람직하 며, 1 중량%로 첨가하는 것이 가장 바람직하다. In particular, Lactobacillus bootsneri according to the present invention can be used to prepare kimchi. Preferably, salted cabbage is mixed with common kimchi seasonings such as red pepper powder, garlic, ginger, leek, radish, and sugar, and then kimchi may be prepared by adding a culture of Lactobacillus bootsnery of the present invention. The culture of the Lactobacillus bootsneri of the present invention is preferably added 0.5 to 5% by weight, and most preferably 1% by weight based on the total weight of kimchi.
본 발명의 락토바실러스 부츠네리는 GABA 생성능이 뛰어나서, 본 발명의 유산균으로 제조된 김치는 혈압강하 및 긴장완화 효과가 있는 GABA 함량이 높은 기능성 김치를 제조할 수 있게 된다.Lactobacillus bootsnery of the present invention is excellent in GABA generating ability, kimchi prepared with lactic acid bacteria of the present invention can be produced high functional kimchi with a high GABA content to reduce blood pressure and relax the effect.
본 발명에 따른 락토바실러스 부츠네리는 통상적인 락토바실러스 속 미생물의 배양방법에 의해 대량으로 배양할 수 있다. 배양배지로는 탄소원, 질소원, 비타민 및 미네랄로 구성된 배지를 사용할 수 있으며, 예컨대, MRS(Man-Rogosa-Sharp) 배지 또는 배추즙 배지를 사용할 수 있다. 상기 배추즙배지는 배지는 절임배추를 분쇄하고 착즙한 후, 멸균하여 사용할 수 있다. 미생물의 배양은 통상의 락토바실러스속 미생물의 배양 조건상에서 가능하며, 예컨대, 10℃ 내지 30℃에서 24시간 내지 60시간 정도 배양할 수 있다. 보다 바람직하게는 30℃에서 48시간 정도 배양하는 것이 바람직하다. 배양액 중의 배양배지를 제거하고 농축된 균체만을 회수하기 위해 원심분리 또는 여과과정을 거칠 수 있으며, 이러한 단계는 당업자가 필요에 따라 수행할 수 있다. 농축된 균체는 통상적인 방법에 따라 냉동(frozen)하거나 또는 냉동건조(lyophilized)하여 그 활성을 잃지 않도록 보존할 수 있다. Lactobacillus butnery according to the present invention can be cultured in large quantities by a conventional method for culturing the genus Lactobacillus. As the culture medium, a medium consisting of a carbon source, a nitrogen source, vitamins, and minerals may be used. For example, MRS (Man-Rogosa-Sharp) medium or Chinese cabbage juice medium may be used. The cabbage juice medium can be used by sterile after crushing and juice the pickled cabbage medium. Cultivation of the microorganism is possible under the culture conditions of the common Lactobacillus microorganisms, for example, can be incubated for 24 to 60 hours at 10 ℃ to 30 ℃. More preferably, it is preferable to incubate at 30 ° C for about 48 hours. Centrifugation or filtration may be performed to remove the culture medium in the culture and recover only the concentrated cells, which steps may be performed by those skilled in the art as needed. The concentrated cells may be frozen or lyophilized according to a conventional method so as not to lose their activity.
이하, 본 발명을 실시예에 의해 상세히 설명한다.Hereinafter, the present invention will be described in detail by way of examples.
단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시 예에 한정되는 것은 아니다.However, the following examples are merely to illustrate the invention, but the content of the present invention is not limited to the following examples.
<< 참고예Reference Example 1> 1>
일반김치와 묵은Kimchi and Pasta 김치의 Kimchi GABAGABA 함량 비교 Content comparison
숙성기간이 4개월 미만인 일반 김치로서의 종가집에서 판매하고 있는 “종가집 김치”(pH 3.87) 및 일미식품에서 판매하고 있는 “일미 맛김치”(pH 3.48) 및 종가집에서 판매하고 있는 숙성기간이 6개월 이상인 “종가집 삼겹살 묵은지”(pH 3.48)를 각각 구입하여 각각의 GABA 함량을 역상 고성능 액체 크로마토그래피(HPLC)를 이용하여 정량한 결과를 도 2에 나타내었다.“Kongga House Kimchi” (pH 3.87) sold by Jongga House as a general Kimchi with less than 4 months of ripening, and “Ilmi Flavored Kimchi” (pH 3.48) sold by Ilmi Foods, Chongga Pork Belly Porridge ”(pH 3.48) was purchased and the respective GABA content was quantified using reverse phase high performance liquid chromatography (HPLC).
김치의 국물을 0.45, 25mm의 실린지(syringe) 필터로 여과하여 시료로 사용하였다. 김치 시료를 AccQ-Tag 방법으로 유도체화한 후 선형 구배 조건하에서 분석하여다. HPLC 컬럼으로는 Nova-PakTM C18, 4um 컬럼을 사용하였다. GABA는 약 38분에 검출되었으며, 정확한 정량을 위해 내부 표준물질로서 AABA(Alpha-aminobutyric acid, 알파-아미노뷰티르산)가 사용되었다 (도 1 참조).Kimchi broth was filtered through a 0.45, 25 mm syringe filter and used as a sample. Kimchi samples are derivatized by AccQ-Tag method and analyzed under linear gradient conditions. As the HPLC column, Nova-PakTM C18, 4um column was used. GABA was detected at about 38 minutes, and AABA (Alpha-aminobutyric acid, alpha-aminobutyric acid) was used as an internal standard for accurate quantification (see FIG. 1).
도 2에 나타낸 바와 같이, HPLC로 정량한 결과 일반 김치에 비해 묵은 김치에서 월등히 높은 GABA 함량을 확인할 수 있었고, A사와 B사의 두 김치 중 pH가 낮은 B사의 김치에서의 GABA 함량이 높은 것을 볼 때 김치가 숙성될수록 GABA 함량이 높아진다는 것을 알 수 있다. 이에 따라, 높은 GABA 생성균을 분리하기 위한 추후의 실험은 6개월 이상 묵은 김치로부터 분리 및 동정 실험하였다.As shown in Figure 2, as a result of quantitative analysis by HPLC was able to confirm the significantly higher GABA content in the old kimchi compared to the normal kimchi, when the high of the GABA content in the kimchi of B company of the low pH of the two kimchi of A company and B company As kimchi matures, the GABA content increases. Accordingly, further experiments for separating high GABA-producing bacteria were separated and identified from kimchi 6 months old or older.
<< 실시예Example 1> 1>
락토바실러스Lactobacillus 부츠네리Bootsnery 균주의 분리 Isolation of Strains
<1-1> 김치로부터 유산균의 분리<1-1> Isolation of Lactic Acid Bacteria from Kimchi
통상적인 김치 제조방법으로 제조된 김치를 7개월 숙성시킨 묵은 김치의 국물을 121℃에서 15분간 살균시킨 거즈를 이용하여 여과하고 그 여액을 121℃에서 15분간 살균시킨 0.9% 식염수로 10-1 내지 10-8의 농도로 희석하였다. MRS 55g과 2% 아가(agar)를 1L의 증류수에 녹인 후 0.002% 브로모페놀 블루(bromophenol blue)를 첨가한 MRS 배지에, 김치 국물 희석액을 도말하고 30℃에서 48시간 동안 배양하였다. The broth of the kimchi manufactured in a conventional manufacturing method kimchi old kimchi was aged 7 months was filtered through a sterilized 15 minutes at 121 ℃ gauze and the filtrate in 121 ℃ with 0.9% sodium chloride solution was sterilized 15 minutes to about 10 -1 Dilute to a concentration of 10 −8 . 55 g of MRS and 2% agar were dissolved in 1 L of distilled water, and then diluted with Kimchi broth in MRS medium to which 0.002% bromophenol blue was added and incubated at 30 ° C. for 48 hours.
락토바실러스균 선택배지인 MRS 배지 위에 자란 균들 중 원형이며 밝은 파랑 색 또는 하얀색을 띄는 균은 락토바실러스균으로 분류된다. 따라서 MRS 배지 위에 자란 균들 중에서 원형이며 밝은 파랑 색 또는 하얀색을 띄는 균들을 선택하여 MRS 55g을 증류수 1L에 녹인 MRS 브로스에 분리 접종한 후 30℃에서 48시간 동안 배양하였다. MRS 55g과 2% 아가를 1L의 증류수에 녹인 후 살균과 플레이트(plate) 과정을 거친 MRS 배지에, 배양된 균들을 스트리킹한 후 30℃에서 48시간 동안 배양하였다. TSB(Tryptic Soy Broth) 30g을 1L의 증류수에 녹인 후 1%의 MSG(monosodium glutamate)를 첨가한 TSB 브로스에 상기에서 배양된 균주를 넣고 30℃에서 48시간 동안 배양하여 73개의 균주를 분리하였다.Among the bacteria grown on MRS medium, Lactobacillus selective medium, circular, light blue or white bacteria are classified as Lactobacillus. Therefore, among the bacteria grown on the MRS medium, the circular, light blue or white bacteria were selected and inoculated separately in MRS broth dissolved in MRS 55g in 1 L of distilled water and incubated at 30 ° C. for 48 hours. 55 g of MRS and 2% agar were dissolved in 1 L of distilled water, sterilized and plated in a cultured MRS medium. After dissolving 30 g of TSB (Tryptic Soy Broth) in 1 L of distilled water, 1% MSG (monosodium glutamate) was added to TSB broth, and the above cultured strains were incubated at 30 ° C. for 48 hours to isolate 73 strains.
TLC 플레이트를 전개 통 크기에 적당한 크기로 자른 후에 하단에서 1cm 높이에 상기에서 분리된 각 균주의 배양 상등액을 1점적한 후에 TLC 전개 통에 넣고 전 개용액을 약 3시간 전개시켰다. 전개용액의 조성은 부탄올:아세트산:물 = 1:1:1 (v/v) 이었다. 전개시킨 TLC 플레이트를 꺼내고 충분히 말린 후 닌하이드린 용액을 분무한 후에 105℃에서 10분간 건조시켜 GABA의 붉은 보라색 위치를 확인한 결과의 일부를 도 3에 나타내었다. After the TLC plate was cut to a size suitable for the size of the development tube, one drop of the culture supernatant of each strain isolated above at 1 cm from the bottom was placed in the TLC development tube, and the entire solution was developed for about 3 hours. The composition of the developing solution was butanol: acetic acid: water = 1: 1: 1 (v / v). After the developed TLC plate was taken out and dried sufficiently, the ninhydrin solution was sprayed, and then dried at 105 ° C. for 10 minutes to confirm the reddish purple position of GABA.
상기와 같이 박층 크로마토그래피(TLC)하여 감마-아미노뷰티르산(GABA) 생성균을 1차적으로 선별한 결과 하기 표 1에 기재되어 있는 10개의 균주에서 가바의 생성량이 높은 것으로 나타났다. 10개 균주에서 생성된 가바의 생성량을 상기 <참고예 1>에 기재되어 있는 고성능 액체 크로마토그래피(HPLC)와 동일한 방법으로 정량하여 하기 표 1에 기재하였다. 하기 표 1에 기재되어 있는 균 중에서 가바 생성능이 가장 높은 H-W3 균주를 최종적으로 선별하였다.As a result of the above-described thin layer chromatography (TLC), gamma-aminobutyric acid (GABA) -producing microorganisms were primarily selected. The amount of Gaba produced in 10 strains was quantified by the same method as high performance liquid chromatography (HPLC) described in Reference Example 1, and is shown in Table 1 below. Among the bacteria described in Table 1, H-W3 strain having the highest Gaba production capacity was finally selected.
상기에서 선별된 H-W3 균주를 TSB 브로스에 0.5g 접종하여 30℃에서 24시간 배양하여 증식시켰다. 완전히 증식된 균주를 함유하는 TSB 브로스 1ml를 멸균 튜브에 넣고 8000rpm에서 10분간 원심분리하여 균체를 획득하였다. TSB 브로스와 15%의 글리세롤을 잘 섞은 후 1ml를 균체에 넣고 볼텍스 혼합기로 잘 섞어 준 후 즉시 냉동시켰다. 냉동된 균주는 이 후 유산균 접종을 위한 스타터로 사용되었다. The H-W3 strain selected above was inoculated with 0.5 g of TSB broth and grown for 24 hours at 30 ° C. 1 ml of TSB broth containing the fully grown strain was placed in a sterile tube and centrifuged at 8000 rpm for 10 minutes to obtain cells. After mixing TSB broth with 15% glycerol well, 1ml was added to the cells, mixed well with a vortex mixer, and immediately frozen. Frozen strains were then used as starters for lactic acid bacteria inoculation.
<1-2> 선별된 균의 동정<1-2> Identification of Selected Bacteria
상기 <1-1>에서 분리된 균주의 16s rDNA 서열을 결정하여 공시된 균주와 비교하였다. PCR용 정방향 프라이머로는 서열번호 1 (AgAgTTTgATCMTGGCTCAg)을, 역방향 프라이머로는 서열번호 2 (TACggYTACCTTgTTACgACTT)를 사용하였다. 균주 동정을 위한 16s rDNA 염기서열은 다음 과정을 통해 조사되었다. 배지는 MRS 브로스를 사용하였고, 균은 30℃에서 배양하였다. 16s rDNA 세트는 변성 단계를 95℃에서 5분 실시, 증폭 단계를 35 싸이클(94℃ 45초, 55℃ 60초, 72℃ 60초)로 하였고, 연장 단계를 75℃에서 10분으로 하였다. 증폭된 DNA는 1%(w/v) 아가로오즈 젤에 전개하여 16s rDNA 염기서열을 분석한 결과, 락토바실러스 부츠네리의 16S rDNA 염기서열과 99% 동일함을 확인할 수 있었다(결과 미도시).16s rDNA sequence of the strain isolated in <1-1> was determined and compared with the disclosed strain. SEQ ID NO: 1 (AgAgTTTgATCMTGGCTCAg) was used as a forward primer for PCR, and SEQ ID NO: 2 (TACggYTACCTTgTTACgACTT) was used as a reverse primer. 16s rDNA sequence for identifying the strain was examined through the following process. MRS broth was used as a medium, and bacteria were incubated at 30 ° C. In the 16s rDNA set, the denaturation step was performed at 95 ° C for 5 minutes, the amplification step was 35 cycles (94 ° C 45 seconds, 55 ° C 60 seconds, 72 ° C 60 seconds), and the extension step was 75 ° C for 10 minutes. The amplified DNA was developed on a 1% (w / v) agarose gel and analyzed for 16s rDNA sequences. As a result, it was confirmed that the DNA was 99% identical to the 16S rDNA sequences of Lactobacillus bootsneri (results not shown). .
따라서, 본 발명자들은 본 발명에서 분리된 상기 "락토바실러스 부츠네리"를 한국미생물보존센터(Korean Culture Center of Microorganisms)에 2007년 1월 10일자로 기탁하였다(기탁번호: KCCM10835P). Therefore, the present inventors deposited the Lactobacillus butneri isolated in the present invention to the Korean Culture Center of Microorganisms as of January 10, 2007 (Accession No .: KCCM10835P).
<< 실시예Example 2> 2>
본 발명의 유산균의 Of lactic acid bacteria of the present invention GABAGABA 생성량 비교 Generation amount comparison
본 발명의 락토바실러스 부츠네리의 GABA 생성량의 정도를 확인하기 위하여 대조군으로 락토바실러스 카제이(Lactobacillus casei, KCCM 12452)와 종래 GABA 생성능이 있다고 알려진 락토바실러스 브레비스(Lactobacillus brevis, KCCM 11509)를 사용하였다. 각 유산균을 50mM 글루타메이트(Glutamate)가 첨가된 MRS 브로스 10ml 씩 각각 접종하였다. 30℃에서 3일동안 배양한 후 상기 <참조예 1>에 기재되어 있는 방법과 동일하게 HPLC로 GABA를 정량하여 그 결과를 도 4에 나타내었다. In order to confirm the degree of GABA production of Lactobacillus bootsneri of the present invention, Lactobacillus casei (KCCM 12452) and Lactobacillus brevis (Lactobacillus brevis, KCCM 11509) known to have a conventional GABA production capacity were used as a control. Each lactic acid bacterium was inoculated with 10 ml of MRS broth to which 50 mM glutamate was added. After incubating at 30 ° C. for 3 days, GABA was quantified by HPLC in the same manner as described in Reference Example 1, and the results are shown in FIG. 4.
도 4에 나타낸 바와 같이, 본 발명의 락토바실러스 부츠네리는 종래 락토바실러스 카제이 균주 및 GABA 생성능이 있다고 알려진 락토바실러스 브레비스에 비하여 약 10배 이상의 GABA 생성능을 갖는 것을 확인할 수 있었다.As shown in Figure 4, the Lactobacillus bootsneri of the present invention was confirmed to have a GABA production capacity of about 10 times or more compared to the Lactobacillus brevis known to have a conventional Lactobacillus casei strain and GABA production capacity.
<< 제조예Production Example >>
분리된 균주를 이용한 김치의 제조Preparation of Kimchi Using Isolated Strains
상기 <실시예 1>에서 분리한 GABA 고생성능 균을 김치 제조시 김치 양념과 함께 절인 배추에 첨가하였다.GABA high-performance bacteria isolated in <Example 1> was added to the pickled cabbage with kimchi seasoning when preparing kimchi.
먼저, 배추를 반으로 절단하여 천일염 8%를 첨가하고 7%의 소금물이 채워진 절임통 속에 넣어 4~5 시간 동안 침수시킨 후(배추 절임공정), 절여진 배추를 흐르는 물에 세척하고 탈수대에 쌓아서 4℃의 냉장고에서 24시간 동안 자연 탈수시키고, 상기의 탈수된 배추의 밑부분을 제거한 후 3~5cm 의 크기로 절단하는 배추의 전처리 공정을 수행하였다. 김치 양념의 배합공정을 살펴보면, 배추 100 중량부에 대해, 고춧가루 17~18 중량부, 멸치액젓 18~19 중량부, 새우젓 7~8 중량부, 간마늘 6~7 중량부, 간생강 0.5~1 중량부, 이온 물엿 5~6 중량부, 설탕 0.5 중량부 및 L-글루탐산나트륨(MSG) 0.65~0.69 중량부를 배합하여 김치 양념 배합공정을 수행하였다.First, cut the Chinese cabbage in half, add 8% of natural salt, put it in a pickling container filled with 7% salt water, and soak it for 4-5 hours (picking cabbage), then wash the pickled cabbage under running water and put it on the dehydration table. Stacked and naturally dehydrated for 24 hours in a refrigerator at 4 ℃, remove the bottom of the dehydrated cabbage was carried out a pre-treatment process of the cabbage cut to a size of 3 ~ 5cm. Looking at the blending process of kimchi seasoning, with respect to 100 parts by weight of cabbage, 17-18 parts by weight of red pepper powder, 18-19 parts by weight of anchovy sake, 7-8 parts by weight of salted shrimp, 6-7 parts by weight of garlic, 0.5-1 A kimchi seasoning mixing process was performed by blending 5 parts by weight, 5 parts by weight of ionic starch syrup, 0.5 parts by weight of sugar, and 0.65-0.69 parts by weight of sodium L-glutamate (MSG).
절인 배추에, 상기 <실시예 1>에서 분리한 락토바실러스 부츠네리를 105 내지 107 cfu/ml의 양으로 첨가하고 김치 양념을 첨가하여 골고루 버무려서 김치를 제조한 후 10 내지 30℃에서 발효시켰다.Pickled Chinese cabbage, isolated in Example 1 Lactobacillus bootsneri was added in an amount of 10 5 to 10 7 cfu / ml, and kimchi seasoning was added to make the kimchi evenly, followed by fermentation at 10 to 30 ° C.
이상 살펴본 바와 같이, 본 발명의 신규한 락토바실러스 부츠네리는 GABA 생성능이 우수하다. 따라서 본 발명의 유산균은 정장제, 생균제, 사료첨가제, 식품첨가제 및 발효제품의 제조에 다양하게 이용될 수 있다. 특히, 본 발명에 따른 락토바실러스 부츠네리를 스타터로 이용하여 김치를 제조하는 경우, 혈압강하 및 신경완화 효과가 있는 GABA를 다량하는 기능성 김치를 제조할 수 있다.As described above, the novel Lactobacillus bootneri of the present invention is excellent in GABA generation ability. Therefore, the lactic acid bacteria of the present invention can be used in various forms for the preparation of formal preparations, probiotics, feed additives, food additives and fermented products. In particular, when the kimchi is prepared using the Lactobacillus bootsneri according to the present invention as a starter, it is possible to produce a functional kimchi having a large amount of GABA having a blood pressure lowering and neuroleptic effect.
<110> PARK, Hyun Jin <120> Novel Lactobacillus buchneri and use thereof <130> NP07-0005 <160> 2 <170> KopatentIn 1.71 <210> 1 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> forward primer <400> 1 agagtttgat cmtggctcag 20 <210> 2 <211> 22 <212> DNA <213> Artificial Sequence <220> <223> reverse primer <400> 2 tacggytacc ttgttacgac tt 22 <110> PARK, Hyun Jin <120> Novel Lactobacillus buchneri and use <130> NP07-0005 <160> 2 <170> KopatentIn 1.71 <210> 1 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> forward primer <400> 1 agagtttgat cmtggctcag 20 <210> 2 <211> 22 <212> DNA <213> Artificial Sequence <220> <223> reverse primer <400> 2 tacggytacc ttgttacgac tt 22
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070018641A KR100910657B1 (en) | 2007-02-23 | 2007-02-23 | Novel Lactrobacillus buchneri and use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070018641A KR100910657B1 (en) | 2007-02-23 | 2007-02-23 | Novel Lactrobacillus buchneri and use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20080078460A true KR20080078460A (en) | 2008-08-27 |
KR100910657B1 KR100910657B1 (en) | 2009-08-05 |
Family
ID=39880642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070018641A KR100910657B1 (en) | 2007-02-23 | 2007-02-23 | Novel Lactrobacillus buchneri and use thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100910657B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102987435A (en) * | 2012-11-13 | 2013-03-27 | 西华大学 | Preparation method for multifunctional complex-fermented powder for tenderization and fermentation and method for preparing fermented yak meat particles |
KR102221579B1 (en) * | 2019-11-18 | 2021-03-02 | 건국대학교 산학협력단 | NOVEL STRAIN OF Lactobacillus buchneri AND USE THEREOF |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101427415B1 (en) | 2013-05-08 | 2014-08-07 | 조선대학교산학협력단 | Lactic acid bacterium separated from kimchii and fermented food using the strain |
KR101917497B1 (en) | 2017-02-18 | 2018-11-09 | 박병희 | Novel Lactobacillus buchneri and Use thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0262A (en) * | 1989-04-07 | 1990-01-05 | Daicel Chem Ind Ltd | Photomask cover |
KR100549094B1 (en) | 2003-01-29 | 2006-02-06 | 변유량 | Novel Strains of Lactobacillus spp. and Method for Preparing ?-Aminobutyric Acid Using the Same |
KR100631857B1 (en) | 2004-07-15 | 2006-10-09 | 전북대학교산학협력단 | -3 Lactobacillus Brevis OPK-3 Having a High Production Ability of Gamma-Aminobutyric Acid |
-
2007
- 2007-02-23 KR KR1020070018641A patent/KR100910657B1/en active IP Right Grant
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102987435A (en) * | 2012-11-13 | 2013-03-27 | 西华大学 | Preparation method for multifunctional complex-fermented powder for tenderization and fermentation and method for preparing fermented yak meat particles |
KR102221579B1 (en) * | 2019-11-18 | 2021-03-02 | 건국대학교 산학협력단 | NOVEL STRAIN OF Lactobacillus buchneri AND USE THEREOF |
Also Published As
Publication number | Publication date |
---|---|
KR100910657B1 (en) | 2009-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101124660B1 (en) | fermented fruits and vegetables and compositions comprising the same | |
CN109810912B (en) | Lactobacillus plantarum LH-511 and application thereof | |
KR101514335B1 (en) | Lactic acid bacterial salt using fermentates thereof and lactic acid bacterial powder | |
CN111534459A (en) | Lactobacillus fermentum for high yield of amylase and application of lactobacillus fermentum in preparation of fermented feed | |
JP4313615B2 (en) | Novel lactic acid bacteria having immunostimulatory activity and γ-aminobutyric acid producing ability, and use thereof. | |
KR20230154400A (en) | Lactobacillus plantarum hom3201 strain and its live bacterial preparation, preparation method and application | |
KR100910657B1 (en) | Novel Lactrobacillus buchneri and use thereof | |
KR102130646B1 (en) | Novel lactobacillus salivarius and feed additives for aquacultural fish and crustacea comprising the same | |
KR101039620B1 (en) | Distinct culture technique of flounder by using orange concentrate and acanthopanax koreanum from jeju | |
KR20150054056A (en) | Fermentation feed comprising brown algae by-products | |
KR20130107940A (en) | Method of producing fermented red ginseng | |
KR101627806B1 (en) | The culturing method for increasing immune-enhancing activity in Lactobacillus spp. | |
CN116064285B (en) | Lactobacillus rhamnosus ZJUIDS07 capable of reducing blood sugar and application thereof | |
KR20060037705A (en) | Extract having growth-inhibiting and promoting effects of human intestinal bacteria extracted from valley potato cultivars and functional food using the same | |
KR100769299B1 (en) | Lactobacillus fermentum and dairy products and health-promoting food containing the same | |
KR20140022652A (en) | New leuconostoc citreum and food including the same | |
KR20220094359A (en) | Method for manufacturing Morinda citrifolia fortified with higher GABA content using Lactic acid bacteria having GABA-producing activity | |
JP4068103B2 (en) | Production method of vitamin K by culture of Yunnan SL-001 | |
KR20220059972A (en) | Lactobacillus fermented product containing vitamin K2, and composition for preventing or treating inflammation containing same | |
CN116656526B (en) | Lactobacillus plantarum JF4 and application thereof in preparation of blood sugar and cholesterol reducing foods and medicines | |
CN114651983B (en) | Bacillus coagulans with uric acid reducing and antioxidant capabilities and derived from shrimp paste, method and application | |
CN114591863B (en) | Tibetan pig source fungicide combination for improving growth performance and immune function of weaned piglets | |
CN114712485B (en) | Application of lipopeptide surfactin in preventing or relieving type II diabetes | |
KR102202092B1 (en) | Weissella koreensis nd824 strain having improved productivity of ornithine and composition comprisingng the same | |
KR101912299B1 (en) | Saccharomyces exiguus having capacity of inhibiting growth and development of Saccharomyces, composition comprising the same and method for manufacturing fermented food using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130621 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20140630 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20151026 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20170321 Year of fee payment: 8 |
|
R401 | Registration of restoration | ||
FPAY | Annual fee payment |
Payment date: 20170707 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20180702 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20190715 Year of fee payment: 11 |